Trials / Recruiting
RecruitingNCT06642272
A Pragmatic Trial Comparing Empagliflozin and Dapagliflozin Through Cluster Randomization Embedded in the Electronic Health Record
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 17,200 (estimated)
- Sponsor
- Herlev and Gentofte Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this clinical trial is investigate the comparative effectiveness of empagliflozin and dapagliflozin for the treatment of diabetes, chronic kidney disease, and heart failure. Patients who are prescribed either empagliflozin or dapagliflozin, as part of daily clinical practice at the participating sites, will be included in the study. Treatment will be randomized automatically through the electronic health record software in clusters defined by time of day. https://www.appletreestudy.com
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Empagliflozin 10 MG | Once daily |
| DRUG | Dapagliflozin 10 MG | Once daily |
Timeline
- Start date
- 2024-10-10
- Primary completion
- 2028-12-31
- Completion
- 2028-12-31
- First posted
- 2024-10-15
- Last updated
- 2024-11-05
Locations
12 sites across 1 country: Denmark
Source: ClinicalTrials.gov record NCT06642272. Inclusion in this directory is not an endorsement.